Lung Diseases Cies Search Engine [selected websites]

Loading

Aug 4, 2008

Innovotech : The Hospital for Sick Children and St Michael's Hospital to Evaluate bioFILM PA Test

July 29, 2008 - Innovotech Inc. (TSX VENTURE:IOT) is pleased to announce a three year study by the Hospital for Sick Children and St. Michael's Hospital to evaluate bioFILM PATM, Innovotech's novel biofilm antimicrobial susceptibility test, in the selection of antibiotics to treat lung infections in cystic fibrosis patients.

"bioFILM PATM is a Health Canada registered product, and is therefore available for use by physicians and diagnostic laboratories in the treatment of a host of biofilm respiratory infections" says Dr Bhavin Rawal, Product Manager, Innovotech. "Our early results in cystic fibrosis show promise, so it is appropriate to continue the evaluation of bioFILM PATM, particularly with the Hospital for Sick Children and St Michael's Hospital, given their international reputation in this field."... Innovotech's Press Release -